User login
Article Type
Changed
Wed, 10/06/2021 - 14:31
Display Headline
Psoriasis and Psoriatic Arthritis: A Supplement to Dermatology News
Psoriasis and Psoriatic Arthritis: A Supplement to Dermatology News 2021
- Psoriasis severity redefined by expert group
- Mitigating PSA risk with biologic therapy
- Lack of diversity seen in psoriasis trials
- PSA Comorbidities effect on treatment responses
With Commentaries by Joel M. Gelfand, MD, MSCE and Alan Menter, MD
And more…
Publications
Sections
Psoriasis and Psoriatic Arthritis: A Supplement to Dermatology News 2021
- Psoriasis severity redefined by expert group
- Mitigating PSA risk with biologic therapy
- Lack of diversity seen in psoriasis trials
- PSA Comorbidities effect on treatment responses
With Commentaries by Joel M. Gelfand, MD, MSCE and Alan Menter, MD
And more…
Psoriasis and Psoriatic Arthritis: A Supplement to Dermatology News 2021
- Psoriasis severity redefined by expert group
- Mitigating PSA risk with biologic therapy
- Lack of diversity seen in psoriasis trials
- PSA Comorbidities effect on treatment responses
With Commentaries by Joel M. Gelfand, MD, MSCE and Alan Menter, MD
And more…
Publications
Publications
Article Type
Display Headline
Psoriasis and Psoriatic Arthritis: A Supplement to Dermatology News
Display Headline
Psoriasis and Psoriatic Arthritis: A Supplement to Dermatology News
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article